Antibodies from recovered patients recognize a lesser-known site on the pandemic coronavirus and block infection in lab studies
Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models.
These National Institutes of Health grants will support trailblazing ideas for solving critical questions in biomedical science.
Dubbed “The Oscars of Science,” Baker’s award recognizes stellar achievements in building protein molecules from scratch to perform vital functions.
Computer-designed, synthetic miniproteins act as potent, stable antivirals that block coronavirus infection of cultured human cells.
Our bodies create antibodies to recognize, neutralize and clear specific pathogens. That's why scientists are looking at neutralizing anbodies as models for therapies against the new coronavirus, SARS-CoV-2.
Several new findings on how the virus’ cell entry tools operate could expedite the design of vaccines, antibodies, antivirals and other therapeutics.
UW Medicine researchers have been working around the clock on the novel coronavirus.
Biochemical reasons for lag times between conception and pregnancy in mice became clearer in a recent study
A monoclonal antibody prevents the virus from fusing with cell membranes to gain entry
